GlycoMimetics Inc

Finanzen von GlycoMimetics Inc (GLYC)

$15.700

-0.851 (-5.42%)Zum Schluss

Profitabilität und Margen von GLYC

Evaluating the bottom line, GlycoMimetics Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -182.66%, provide a clear picture of how effectively GLYC converts its operational activities into shareholder value.

GLYC im Vergleich zur Peergroup

In the context of the broader market, GLYC competes directly with industry leaders such as APRE and TLPH. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, GLYC's gross margin of N/A stands against APRE's N/A and TLPH's N/A. Such benchmarking helps identify whether GlycoMimetics Inc is trading at a premium or discount relative to its financial performance.

Financials

FY2024Q4
YoY:
-100.00%
0.00
Total Revenue
FY2025Q1
YoY:
-78.42%
-2.40M
Operating Profit
FY2025Q1
YoY:
-78.17%
-2.34M
Net Income after Tax
FY2025Q1
YoY:
-76.47%
-0.04
EPS - Diluted
FY2025Q1
YoY:
-51.45%
-5.11M
Free Cash Flow
FY2023Q4
YoY:
0.00%
100.00
Gross Profit Margin - %
FY2024Q3
-350.22K
FCF Margin - %
FY2023Q4
YoY:
+45.84%
-90.79K
Net Margin - %

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten